Dr. Francisco Ward named Chief Medical Officer of Bazelet Health Systems

Rhea-AI Summary

Bazelet Health Systems, a subsidiary of Neon Bloom, Inc. (OTC: NBCO), has appointed Dr. Francisco Ward as its new Chief Medical Officer. Dr. Ward, a graduate of Johns Hopkins School of Medicine, brings over 25 years of medical expertise and leadership, particularly in the endocannabinoid system and medical cannabis. He is tasked with overseeing Bazelet's healthcare programs, clinical research, and patient experience standards from the Columbia, Maryland office. His appointment emphasizes Bazelet's commitment to effective medical treatment through advanced research and patient-centered care.

Positive

• Appointment of Dr. Francisco Ward, a highly qualified medical professional, as Chief Medical Officer.
• Dr. Ward has over 25 years of experience, enhancing Bazelet's leadership in the healthcare sector.
• Focus on effective medical treatment and patient-centered healthcare aligns with current industry trends.

Negative

• None.

COLUMBIA, Md., April 8, 2021 /PRNewswire/ -- Neon Bloom, Inc. (OTC: NBCO) -- Bazelet Health Systems, Inc. ("BHS") introduces Board Certified Dr. Francisco Ward as their new chief medical officer (CMO). Dr. Ward is a DEA licensed physician, graduate of Johns Hopkins School of Medicine and founder of Seton Pain & Rehabilitation Center. Dr. Ward has worked with the Maryland Board of Physicians and the DEA successfully for many years and combines trusted traditional medical background with substantial eloquence on the human endocannabinoid system, "ECS" and the cannabinoid landscape.

Dr. Francisco Ward, graduate of Johns Hopkins School of Medicine named Chief Medical Officer of Bazelet Health Systems.

Dr. Ward, working from the Company's Columbia, Maryland medical offices will be responsible for the execution of Bazelet's healthcare programs, clinical research, and patient experience standards. As CMO, Dr. Ward will manage relationships with US healthcare entities, insurers, regulators and the global medical and research community.

Selected as a greater Baltimore region "Top Doc", Dr. Ward has served as Maryland State Medical Society chair of the medical cannabis Task Force. His expert understanding of the endocannabinoid system, the musculoskeletal system and its influences on other body systems align with Bazelet Health's priorities.

David Grand, Director of Research for Bazelet states "I am excited and confident in Dr. Ward. His substantial knowledge and experience as a practitioner and as a healthcare board member, is trusted to run Bazelet Health's medical practice. Dr. Ward will lead BHS on its deliberate strategy of effective medical treatment and patient experience through exceptional phyto-genetics, clinical research and reimagined, patient centered healthcare."

"Dr. Ward brings over 25 years medical knowledge, healthcare leadership, and patient care experience. Those skillsets and being well learned in the human ECS and cannabinoids make Dr. Ward well suited to lead a modern-day healthcare company like Bazelet Health. We are pleased to welcome him to our organization." Said Bazelet co-founder and Medical Director Steven Salsburg, MD.

About Neon Bloom, Inc. 
Neon Bloom, Inc. wholly owns Bazelet Health Systems, Inc. (BHS). BHS is the global forefront of the legal cannabis industry and represents a deliberate strategy to create a centralized focus on effec­tive medical treatment and healthcare through exceptional genetics, research, and education.

Disclaimer:
This Press Release is for informational purposes, contains forward-looking statements based on current expectations, forecasts, and assumptions with information available to us as of the date hereof and involve risks and uncertainties. This Press Release does not constitute an offer to sell or a solicitation of offers to buy any securities of any entity. Actual results may differ materially from those stated or implied in such forward-looking statements. Forward-looking statements include statements regarding our expectations, beliefs, intentions or strategies regarding the future and can be identified by forward-looking words such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "should," "would" or similar words. We assume no obligation to update the information included in this Press Release, whether a result of new information, future events or otherwise.

CONTACT: Robyn Frick
PHONE: (321) 430-0404 ext. 2105
EMAIL: support@bazelethealth.com  
WEBSITE: www.bazelethealth.com  

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/dr-francisco-ward-named-chief-medical-officer-of-bazelet-health-systems-301264796.html

SOURCE Bazelet Health

FAQ

Who is Dr. Francisco Ward and what is his role at Bazelet Health Systems?

Dr. Francisco Ward is the new Chief Medical Officer of Bazelet Health Systems, responsible for overseeing healthcare programs and clinical research.

What experience does Dr. Ward bring to Bazelet Health Systems?

Dr. Ward has over 25 years of medical expertise, particularly in the endocannabinoid system and medical cannabis.

When was Dr. Francisco Ward appointed as Chief Medical Officer?

Dr. Francisco Ward was appointed as Chief Medical Officer on April 8, 2021.

What does Bazelet Health Systems focus on under Dr. Ward's leadership?

Bazelet Health Systems focuses on effective medical treatment, clinical research, and enhancing patient experience.

What is the stock symbol for Neon Bloom, Inc.?

The stock symbol for Neon Bloom, Inc. is NBCO.